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Due to widespread and indiscriminate use of conventional antibiotics, bacteria have acquired a resistant 
phenotype in response to those antimicrobials pressure. Therefore, microbial infections associated with biofilms 
have become hard to treat with conventional therapy. The development of microbial drug resistance and drug-
related toxicity has promoted the search for new alternatives, to control, mostly, healthcare-associated infections. 
Terpinen-4-ol is the major component of tea tree essential oil and has shown strong antimicrobial properties as a 
single agent against planktonic cultures. Colistin is an antimicrobial peptide with great antimicrobial activity, 
essentially against Gram-negative bacteria, such as P. aeruginosa.  
The aim of this study was to explore the synergism between terpinen-4-ol and colistin, using low doses of each 
natural antimicrobial, to control the establishment of P. aeruginosa biofilms. Biofilms were formed in the 
presence of both antmicrobials, alone or in combination, being after characterized by total biomass, through 
crystal violet, and number of cultivable bacterial cells (log CFU/cm2). 
Data related with the individual antimicrobial activity of terpinen-4-ol revealed that the biomass of P.aeruginosa 
biofilms was significantly reduced for 0.19 % (v/v), though it not affected the viability of cells even for the 
highest concentration tested (0.38 % (v/v)). On the other hand, colistin promoted a significantly reduction of the 
biofilm mass but only for concentrations higher than 1 μg ml-1. The number of viable cells entrapped within the 
biofilms was only affect for colistin doses higher for 4 μg ml-1. The association of terpinen-4-ol (0.19 % (v/v)) 
with colistin revealed to be a very efficient prophylactic strategy, as it impaired significantly biofilm formation. 
In fact, it was observed biofilm mass reductions closed to 100 % and significant decreases of the numbers of 
viable biofilm-cells (3-5 log of reduction) even for the lowest colistin concentration tested (0.5 μg ml-1). 
These data highlighted the promising antibiofilm activity of association of natural compounds, as antimicrobial 
peptides and secondary metabolites of essential oils, suggesting that this combination may have prophylactic 
potential for the prevention of P. aeruginosa biofilm-associated infections.  
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Infectious diseases are challenged by using chemicals (antimicrobials, non-antibiotic biocides), physical 
treatments, and also by strengthening the innate immune system (immunotherapy, immunomodulating agents, 
cytokines, etc.). Among this last category the developing of novel vaccines explores the use of different 
production platforms that could be advantageous both regarding the speed of vaccine production and the 
economy of the process. Considering the time needed to develop a production process the main concern is to 
have a platform that could give a fast response to face an epidemic outbreak. One of the attractive alternatives is 
the plant platform which has already demonstrated its capacity to express recombinant proteins, e.g.: antibodies 
and their fragments, enzymes, and also immunogens. We propose the use of a plant platform for expressing 
candidate antigens for a new generation of vaccines. 
In our laboratory we have demonstrated the efficiency of a plant platform based on Nicotiana tabacum for 
expressing the glycoprotein E2, which is the main immunogen of the virus responsible of the Bovine Viral 
Diarrhoea (BVD), a disease broadly distributed in the world.  Specifically, we have expressed a truncated version 
of that protein (without its transmembrane domain); the construct also bears specific sequences for the successful 
expression of the protein in plants (the Arabidopsis 2S2 signal replacing the ss viral secretory signal peptide, the 
Kozak sequence, and the KDEL ER- retention signal). The promoter and terminator used were from the 
Cauliflower Mosaic Virus (CaMV35S). The expression of the truncated version of E2 (tE2) was performed by 
infecting the N. tabacum leaves with an Agrobacterium tumefaciens strain bearing the designed construct. 
When the E2 glycoprotein was transiently expressed in tobacco leaves, the MW of the expressed protein was as 
expected (35 kDa), the highest yield obtained after 4 days of inoculation was 20 
g g-1 of infected leaf, 
corresponding to 1,3 % of total soluble protein content. The ability of developing the production of neutralizing 
antibodies was tested by vaccinating both guinea pigs (which is an accepted animal model for testing BVDV 
vaccines) and cattle with two formulations containing the plant extract and an oily (Montanide ISA 70 
SEPPIC®) or an aqueous adjuvant (Al(OH)3). Animals were primed and boosted with 0.5 ml (guinea pigs) or 
5.0 ml (cattle) of a vaccine formulated combining the adjuvant and an amount of plant extract containing 20 
g 
of antigen both in different relationships. The bleed sera of each animal were used for detecting neutralising 
antibodies by the Virus Neutralization Test (VNT) recommended by OIE and, the specific ELISA was performed 
for quantifying neutralizing antibodies anti-E2. High titers of antibodies were obtained from animals inoculated 
with the plant-made vaccine. In both cases the response was positive besides the typical individual heterogeneity 
of any animal model. Also, the sero-conversion obtained suggests a good potential performance for the 
recombinant antigen. The VNT demonstrated the induction of neutralising antibodies after inoculating with the 
plant recombinant tE2 vaccine. 
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